|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by HC Wainwright & Co. on May 10, 2021. The analyst firm set a price target for 17.00 expecting CYAD to rise to within 12 months (a possible 214.26% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Celyad Oncology (NASDAQ: CYAD) is $5.4095 last updated Today at 7:20:56 PM.
There are no upcoming dividends for Celyad Oncology.
There is no upcoming split for Celyad Oncology.
Celyad Oncology is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.